|
2023 Conference Publication Determining if osteopontin is an immune checkpoint of KRAS mutant colorectal cancerNowlan, B., Borowsky, J., Dumenil, T., Tria, S., Wright, J., Fennell, L., Bond, C., McKeone, D., Hartel, G., Woods, S., Leggett, B. and Whitehall, V. (2023). Determining if osteopontin is an immune checkpoint of KRAS mutant colorectal cancer. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2023, Brisbane, QLD Australia, 2-5 September 2023. Richmond, VIC Australia: John Wiley & Sons. |
|
2023 Conference Publication KRAS mutant bowel cancers segregate into two distinct subgroupsBorowsky, J., Su, C., Fennell, L., Burge, M., Liu, J., Costa, A. Dias, Ogino, S., Mckeone, D., Olsen, K., Badshah, J., Bond, C., Nowlan, B., Tria, S., Laki, V., Walker, N., Brown, I., Bettington, M., Leggett, B. and Whitehall, V. (2023). KRAS mutant bowel cancers segregate into two distinct subgroups. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2023, Brisbane, QLD Australia, 2-5 September 2023. Hoboken, NJ United States: Wiley. |
